Results summary | View all lists in L2L MDB | View all genes in G03CA.profile.ud50 |
Down-regulated at any timepoint following treatment of WS1 human skin fibroblasts with UVC at a high dose (50 J/m^2) (clusters d1-d9) enrichment: 1.91-fold |
![]() |
![]() | |||||||||||
Probe ID | Name | G | T | D | X | E | P | R | C | S | ![]() |
![]() |
Description |
209048_S_AT | ZMYND8 | ![]() |
![]() |
zinc finger, MYND-type containing 8 | |||||||||
215073_S_AT | NR2F2 | D | E | R | S | ![]() |
![]() |
nuclear receptor subfamily 2, group F, member 2 | |||||
209121_X_AT | NR2F2 | D | E | R | S | ![]() |
![]() |
nuclear receptor subfamily 2, group F, member 2 | |||||
203312_X_AT | ARF6 | T | P | C | S | ![]() |
![]() |
ADP-ribosylation factor 6 | |||||
208937_S_AT | ID1 | D | R | S | ![]() |
![]() |
inhibitor of DNA binding 1, dominant negative helix-loop-helix protein | ||||||
32091_AT | SLC25A44 | T | ![]() |
![]() |
solute carrier family 25, member 44 |